Sign in
4

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001562180-23-006564

Chief Commercial Officer sold 3,477 shares at $393.34 ($1,367,643)

  • Chief Commercial Officer acquired 3,477 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise +1,112 $173.22 $192,621 5,432.16 D
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise +1,588 $274.29 $435,573 7,020.16 D
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise +777 $369.13 $286,814 7,797.16 D
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Sale −3,477 $393.34 $1,367,643 4,320.16 D
Derivatives
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise · Stock Options (Right to buy) −777 $393.34 $305,625 2,331 D
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise · Stock Options (Right to buy) −1,588 $393.34 $624,624 1,588 D
Reiss-Clark Cindy Chief Commercial Officer 2023-08-22 Option exercise · Stock Options (Right to buy) −1,112 $393.34 $437,394 1,756 D
Open-market sales · 3,477 sh · avg $393.34 · $1,367,643
Loading xslF345X05/primarydocument.xml…